Clinical trial
Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa
NCT07518914 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa
- Lead sponsor
- University of Pennsylvania
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 19, 2026
- Completion date
- April 30, 2029
- Enrollment
- 1,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lenacapavir, misinformation